| Literature DB >> 29080374 |
Takeshi Fujii1, Nobuyuki Fujita1, Satoshi Suzuki1, Takashi Tsuji2, Takashi Takaki3,4, Kazuo Umezawa5, Kota Watanabe1, Takeshi Miyamoto1, Keisuke Horiuchi6, Morio Matsumoto1, Masaya Nakamura1.
Abstract
Although the number of patients with intervertebral disc (IVD) degeneration is increasing in aging societies, its etiology and pathogenesis remain elusive and there is currently no effective treatment to prevent this undesirable condition. The unfolded protein response (UPR) is a cellular machinery that plays critical roles in handling endoplasmic reticulum (ER) stress, a condition caused by the accumulation of unfolded proteins in the ER lumen. This study aimed to elucidate the potential role of the UPR mediated by pancreatic endoplasmic reticulum kinase (PERK), one of the major ER stress sensors in mammalian cells, in the development of IVD degeneration. IVD degeneration was artificially induced in Wister rats by percutaneously puncturing the coccyx IVDs and human IVDs were collected from patients who underwent spinal surgery. Expression of the UPR target genes was elevated in degenerative IVDs in both humans and rats. The induction of ER stress in annulus fibrosus cells significantly increased the transcripts for tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6) in a nuclear factor (NF)-κB pathway-dependent manner. The expression of TNF-α and IL-6 was significantly reduced by treatment with a selective PERK inhibitor, GSK2606414, and by gene silencing against PERK and activating transcription factor 4 (ATF4) transcripts. Our findings indicate that the UPR mediated by the PERK pathway is causally related to the development of IVD degeneration, suggesting that PERK may be a potential molecular target for suppressing the degenerative changes in IVDs.Entities:
Keywords: inflammatory cytokines; intervertebral disc degeneration; unfolded protein response
Mesh:
Substances:
Year: 2017 PMID: 29080374 DOI: 10.1002/jor.23787
Source DB: PubMed Journal: J Orthop Res ISSN: 0736-0266 Impact factor: 3.494